Featured post

#Update: Increase in #Human #Infections with #Avian #Influenza #H7N9 Viruses During the 5th #Epidemic — #China, Oct. ‘16–Aug. 7 ‘17 (@CDCgov, edited)

Title : #Update: Increase in #Human #Infections with #Avian #Influenza #H7N9 Viruses During the 5th #Epidemic — #China, Oct. ‘16–Aug. 7 ‘17....

11 Feb 2017

#Influenza and other #Respiratory #Viruses #Research #References #Library–February 11 2017 Issue


Title: #Influenza and other #Respiratory #Viruses #Research #References #Library–February 11 2017 Issue.

Subject: Human and Animal Influenza Viruses, other respiratory pathogens Research, weekly references library update.

Source: AMEDEO, homepage: (LINK).

Code: [  R  ]


This Week’s References:


  1. COLEMAN BL, Hassan K, Green K, Gubbay JB, et al.
    • Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05-2013/14, Toronto, Canada.
  2. TAO W, Hurst B, Shakya AK, Uddin MJ, et al.
    • Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses.
  3. GUAN L, Zhao LQ, Zhou HY, Nie K, et al.
    • Reverse transcription genome exponential amplification reaction assay for rapid and universal detection of human rhinoviruses.
  4. BODDINGTON NL, Verlander NQ, Pebody RG.
    • Developing a system to estimate the severity of influenza infection in England: findings from a hospital-based surveillance system between 2010/2011 and 2014/2015.
  5. LI-KIM-MOY J, Yin JK, Blyth CC, Kesson A, et al.
  6. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al.
    • Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15.
  8. PETRIE JG, Monto AS.
  9. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al.
  10. JIANG W, Wang S, Chen H, Ren H, et al.
    • A bivalent heterologous DNA-virus-like particles prime-boost vaccine elicits broad protection against both groups 1 and 2 influenza A viruses.
  11. MATSUMOTO Y, Ohta K, Kolakofsky D, Nishio M, et al.
    • A point mutation in the RNA-binding domain of human parainfluenza virus type 2 nucleoprotein elicits an abnormally enhanced polymerase activity.
  12. HALL OJ, Nachbagauer R, Vermillion MS, Fink AL, et al.
    • Progesterone-based contraceptives reduce adaptive immune responses and protection against sequential influenza A virus infections.
  13. HMILA I, Wongphatcharachai M, Laamiri N, Aouini R, et al.
  14. FACCINI S, De Mattia A, Chiapponi C, Barbieri I, et al.
  15. LINDER KA, Malani PN.
  16. THONGNOI P, Praphasiri P, Dawood FS, Lindblade KA, et al.
  17. WUMKES ML, van der Velden AM, de Bruin E, Meerveld-Eggink A, et al.
    • Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy.
  18. YUK SS, Erdene-Ochir TO, Kwon JH, Noh JY, et al.
    • Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade H5N8 highly pathogenic avian influenza infection.
  19. BAXTER R, Eaton A, Hansen J, Aukes L, et al.
  20. SANCHEZ-RAMOS EL, Monarrez-Espino J, Noyola DE.
  21. BARMAN S, Krylov PS, Turner JC, Franks J, et al.
    • Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs.
  22. RODRIGUEZ L, Nogales A, Reilly EC, Topham DJ, et al.
  23. LEE YH, Jang YH, Seong BL.


Keywords: Research; Abstract; Influenza References Library.